Found 44 matching trials
REperfusion With P2Y12 Inhibitors in Addition to mEchanical thRombectomy for perFUsion Imaging Selected Acute Stroke patiEnts
PHASE3The main objective is to evaluate the efficacy of IV administration of the ...
The Effect of IV Cangrelor and Oral Ticagrelor Study
PHASE4Major heart attacks are caused by a number of factors, the two major of whi...
Location
The Royal Wolverhampton NHS Trust
Effects of Cangrelor on MIcRovAscular Disfunction During Elective Percutaneous CORonary Intervention
PHASE4Dual Antiplatelet Therapy represents the main therapy for patients presenti...
Location
Division of Cardiology, University Hospital of Ferrara
ARCANGELO (itAlian pRospective Study on CANGrELOr)
N/AThe Sponsor implemented a post-authorisation safety study (PASS), category ...
Randomized Comparison of Cangrelor, Tirofiban and Prasugrel in Patients With STEMI Referred for Primary PCI.
PHASE4Primary percutaneous coronary intervention (PCI) is the main reperfusion th...
Location
University of Ferrara
Dual Antiplatelet Therapy For Shock Patients With Acute Myocardial Infarction
PHASE4Multicenter, international, randomized, placebo-controlled, double-blind tr...
Location
University Hospital Kralovske Vinohrady
Platelet Inhibition to Target Reperfusion Injury
PHASE2There remains a clinical need to improve health outcomes in patients with i...
Location
National University Hospital (NUH)
Cangrelor in Acute Myocardial Infarction: Effectiveness and Outcomes Registry
N/AThe purpose of this registry is to address optimal platelet inhibition duri...
Status
Active Not Recruiting
Location
The Regents of the University of California on behalf of its San Diego campus
Dutch Cangrelor Registry
N/ACangrelor is a fast and directly acting platelet aggregation inhibitor. It ...
Cangrelor Following Ticagrelor Loading vs Ticagrelor Loading Alone in STEMI
PHASE4Platelets and thrombus formation play a key role in the pathogenesis of acu...
Location
Attikon University Hospital